Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic... In the current study, we focused on the role of the nonenhancing region (NER) of glioblastomas and showed that there are imaging phenotypic features related specifically to the NER—most notably the NER crossing the midline and relative cerebral blood volume of NER, which provide important prognostic information; these are complementary to clinical and genomic features and can improve models of patient prognosis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Radiology Radiological Society of North America, Inc.

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

Loading next page...
 
/lp/radiological-society-of-north-america-inc/outcome-prediction-in-patients-with-glioblastoma-by-using-imaging-aNkn0YkIKC

References (36)

Publisher
Radiological Society of North America, Inc.
Copyright
2014 by the Radiological Society of North America, Inc.
Subject
Original Research
ISSN
1527-1315
eISSN
0033-8419
DOI
10.1148/radiol.14131691
pmid
24646147
Publisher site
See Article on Publisher Site

Abstract

In the current study, we focused on the role of the nonenhancing region (NER) of glioblastomas and showed that there are imaging phenotypic features related specifically to the NER—most notably the NER crossing the midline and relative cerebral blood volume of NER, which provide important prognostic information; these are complementary to clinical and genomic features and can improve models of patient prognosis.

Journal

RadiologyRadiological Society of North America, Inc.

Published: Aug 17, 2014

There are no references for this article.